Abstracto

Covid-19, Acute Respiratory Distress Syndrome (ARDS) and Refractory Pulmonary Failure: Inhalation of an Aerosol that Dissolves Thick Pus as an Alternative to Extracorporeal Membrane Oxygenation (ECMO) and Traditional Oral Hygiene Medications

Aleksandr Urakov

The COVID-19 sometimes can induce acute respiratory distress syndrome (ARDS) and refractory pulmonary failure. To save the patient's life, today recommended to urgently using extracorporeal membrane oxygenation (ECMO). However, ECMO technology is not available to everyone in need and is very dangerous for the patients. Therefore, mortality from the new coronavirus disease remains high even in those countries where ECMO is most widely used. However there is still no alternative to ECMO. In particular, there are no medications for individual use for the purpose to remove pus and mucus from the respiratory system and restore pulmonary oxygenation.

The purpose of this study is to offer a worthy alternative to ECMO for airway blockage with pus and mucus in patients and also if they have pus and mucus in the mouth.